Zhivotovsky Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
While these findings are encouraging, its important for our patients to understand that robust human clinical trials are still lacking
Down-regulation of lncRNA NEAT1 enhanced the sensitivity of RCC cells to sorafenib in vitro
For people living with obesity, these medicines offer new, scientifically grounded hope for substantial and meaningful weight loss
(PubMed) Zhang J, Zhou X, Wu W, Wang J, Xie H, Wu Z
Discussing all available options with your physician and a pharmacist is the best way to find a financially sustainable treatment plan